E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Central and nonsplanchnic hemodynamic changes in liver cirrhosis
(Turk J Gastroenterol 1998; 9: 14-20)
Delta infection among children with cronic viral hepatitis
(Turk J Gastroenterol 1998; 9: 21-23)
Effects of Giardia lamblia infestation on the clinical sourse of cronic hepatitis B
(Turk J Gastroenterol 1998; 9: 24-27)
Acral erythema induced bu interferon alpha in a child
(Turk J Gastroenterol 1998; 9: 70-72)
Osteoporosis and bone metabolism in cirrhotic patients
(Turk J Gastroenterol 1998; 9: 95-100)
Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma
(Turk J Gastroenterol 1998; 9: 108-112)
Etiologies of chronic hepatitis
(Turk J Gastroenterol 1998; 9: 113-115)
Apoptosis in selected liver diseases
(Turk J Gastroenterol 2009; 20: 171-179)
DOI: 10.4318/tjg.2009.0003
The prevalence of hepatocellular carcinoma in patients with liver cirrhosis in Southeastern Turkey
(Turk J Gastroenterol 1998; 9: 217-220)
Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey
(Turk J Gastroenterol 2008; 19: 104-108)
The ACE gene I/D polymorphism does not affect the susceptibility to or prognosis of PBC
(Turk J Gastroenterol 2008; 19: 250-253)
Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis
(Turk J Gastroenterol 2007; 18: 245-249)
The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: An analysis of clinical studies
(Turk J Gastroenterol 2006; 17: 25-34)
Daily consensus interferon (CIFN) monotherapy in non-responders or relapsers to a previous interferon regime: One year follow-up after 48 weeks of treatment
(Turk J Gastroenterol 2006; 17: 35-39)
The efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in chronic hepatitis C patients
(Turk J Gastroenterol 2006; 17: 94-98)
Change in plasma concentrations of lipid peroxidation products in patients with acute viral hepatitis
(Turk J Gastroenterol 1999; 10: 4-6)
The value of ultrasonography in the diagnosis of early cirrhosis*
(Turk J Gastroenterol 1999; 10: 7-10)
Gallbladder wall thickening as a sign of esophageal varices in chronic liver disease*
(Turk J Gastroenterol 1999; 10: 11-14)
An asymptomatic huge hepatocellular carcinoma with intra-atrial tumor thrombus in a patient with chronic hepatitis B viral infection
(Turk J Gastroenterol 2006; 17: 203-205)
Assessment of bone metabolism and mineral density in chronic viral hepatitis
(Turk J Gastroenterol 2006; 17: 260-266)
Spontaneous bacterial peritonitis due to Brucella Melitensis in a cirrhotic patient
(Turk J Gastroenterol 2005; 16: 38-40)
Importance of anticoagulant proteins in chronic liver diseases
(Turk J Gastroenterol 2005; 16: 129-133)
Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey
(Turk J Gastroenterol 2005; 16: 183-187)
Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children
(Turk J Gastroenterol 2005; 16: 188-193)
Coeliac disease, autoimmune thyroid disease and primary biliary cirrhosis: Case report
(Turk J Gastroenterol 1999; 10: 167-170)
E-cadherin expression in hepatitis B virus related hepatocelluler carcinoma: Comparison of normal, chronic hepatitis and cirrhotic liver
(Turk J Gastroenterol 1999; 10: 92-94)
The diagnostic role of ultrasonography in liver steatosis
(Turk J Gastroenterol 1999; 10: 96-100)
Successful treatment of primary Sjögren’s syndrome complicated with primary biliary cirrhosis and lung involvement
(Turk J Gastroenterol 2010; 21: 60-62)
DOI: 10.4318/tjg.2010.0051
Serum selenium concentrations in cirrhotic children
(Turk J Gastroenterol 2010; 21: 153-155)
DOI: 10.4318/tjg.2010.0074
Utilization of impedance cardiography in noninvasive assessment of hemodynamic status in cirrhotic patients
(Turk J Gastroenterol 2010; 21: 280-286)
DOI: 10.4318/tjg.2010.0101
The effect of somatostatin infusion on plasma glucagon levels in cirrhotic patients with ascites
(Turk J Gastroenterol 2000; 11: 113-116)
Effect of interferon treatment on glucose metabolism in children with chronic hepatitis B infection
(Turk J Gastroenterol 2004; 15: 4-10)
Esophageal variceal ligation for acute variceal bleeding: Results of three years' follow-up
(Turk J Gastroenterol 2004; 15: 27-33)
Nitric oxide and renal functions in liver cirrhosis
(Turk J Gastroenterol 2004; 15: 73-76)
Cardiovascular problems in cirrhotic patients
(Turk J Gastroenterol 2004; 15: 126-132)
Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha
(Turk J Gastroenterol 2004; 15: 213-218)
Active factor VII levels in patients with cirrhosis
(Turk J Gastroenterol 2001; 12: 100-103)
Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C
(Turk J Gastroenterol 2001; 12: 89-94)
Hepatopulmoner sendrom
(Turk J Gastroenterol 2001; 12: 179-184)
Cerebral magnetic resonance imaging findings in stable cirrhotic patients without clinical signs of hepatic encephalopathy
(Turk J Gastroenterol 2001; 12: 196-202)
Effects of Helicobacter pylori and liver cirrhosis on gastric mucosal hexosamine concentrations
(Turk J Gastroenterol 2001; 12: 206-210)
The increased incidence of vagal neuropathy in cirrhosis
(Turk J Gastroenterol 2001; 12: 258-262)
The level of antithrombin III in cases with primer hepatocellular cancer
(Turk J Gastroenterol 1996; 7: 295-297)
Diagnostic value of color doppler ultrasonography in hepatocellular carcinoma
(Turk J Gastroenterol 1996; 7: 298-302)
Clinicopathologic features and risk factors for hepatocellular carcinoma: Results from a single center in southern Turkey
(Turk J Gastroenterol 2003; 14: 85-90)
Two cases with hepatocellular carcinoma and spleen metastasis
(Turk J Gastroenterol 2003; 14: 138-140)
Spontaneous bacterial peritonitis due to Brucella infection
(Turk J Gastroenterol 2003; 14: 145-147)
Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: Clinical significance and correlation with serological markers
(Turk J Gastroenterol 2003; 14: 157-163)
The use of tissue polypeptide specific antigen as a marker in liver diseases
(Turk J Gastroenterol 2003; 14: 177-180)
Clear cell carcinoma of the liver: A case report
(Turk J Gastroenterol 2003; 14: 211-214)
Two findings of portal hypertension: Evaluation of correlation between serum-ascites albumin gradient and esophageal varices in non-alcoholic cirrhosis
(Turk J Gastroenterol 2003; 14: 219-222)
A comparative immunohistochemical study of HBsAg, HBcAg and CD57 in chronic hepatitis B pediatric patients with and without malignant disorders
(Turk J Gastroenterol 2003; 14: 234-238)
The effect of recombinant hepatitis B vaccine therapy in chronic hepatitis B infection
(Turk J Gastroenterol 2002; 13: 6-10)
The value of fine needle aspiration biopsy in the diagnosis of metastatic liver tumours
(Turk J Gastroenterol 2002; 13: 78-82)
Serum nitric oxide in liver cirrhosis and its relation to blood pressure
(Turk J Gastroenterol 1999; 10: 315-318)
Portal colopathy findings in patients with liver cirrhosis
(Turk J Gastroenterol 1999; 10: 328-333)
Per-oral scintigraphic evaluation of upper portosystemic shunts in portal hypertension
(Turk J Gastroenterol 1999; 10: 340-344)
HDV infection in liver cirrhosis
(Turk J Gastroenterol 1996; 7: 1-5)
The effect of somatostatin analogue (SMS 201-995) on renal function in patients with decompansated cirrhosis and helathy volunteers
(Turk J Gastroenterol 1996; 7: 22-26)
An analysis of our with hepatocellular carcinoma
(Turk J Gastroenterol 1997; 8: 36-40)
Serum digoxin-like immunoreactive substances in chronic liver disease
(Turk J Gastroenterol 1997; 8: 283-285)
histological outcome after interferon therapy in chronic viral hepatitis
(Turk J Gastroenterol 1997; 8: 291-294)
Evaluation of the outcome of interferon therapy in chronic hepatitis B infection
(Turk J Gastroenterol 1999; 10: -)
The early diagnosis of hepatopulmonary syndrome by 99mTc-MAA scintigraphy in chronic liver disease
(Turk J Gastroenterol 1997; 8: 385-391)
Gallbladder wall thickening and emptying function in liver cirrhosis
(Turk J Gastroenterol 1997; 8: 397-401)
Prevalence of osteoporosis in liver cirrhosis
(Turk J Gastroenterol 1997; 8: 156-159)
Relationship of increased serum brain natriuretic peptide levels with hepatic failure, portal hypertension and treatment in patients with cirrhosis
(Turk J Gastroenterol 2010; 21: 381-386)
DOI: 10.4318/tjg.2010.0124
Transmission routes of chronic hepatitis C and their relation to HCV genotypes
(Turk J Gastroenterol 2010; 21: 396-400)
DOI: 10.4318/tjg.2010.0126
Determination of intracellular Th1/Th2 type cytokines in lymphocytes of chronic hepatitis B patients treated with interferon-alpha
(Turk J Gastroenterol 2010; 21: 401-410)
DOI: 10.4318/tjg.2010.0127
Relationship between serum levels of interleukin-10, interleukin-2 and soluble intercellular adhesion molecule-I and liver injury in chronic hepatitis B virus infection
(Turk J Gastroenterol 1999; 10: 243-248)
HCV genotypes in HCV related chronic hepatitis in Southeast Anatolia
(Turk J Gastroenterol 1999; 10: 249-252)
Liver cell adenoma in a male patient with cirrhosis
(Turk J Gastroenterol 1997; 8: 247-250)
Review
Importance of malnutrition in patients with cirrhosis
(Turk J Gastroenterol 2015; 26: 291-296)
DOI: 10.5152/tjg.2015.0224
Peri and postoperative pulmonary complications among cirrhotic individuals
(Turk J Gastroenterol 2004; 15: 207-212)
Emerging therapeutics and relevant targets for chronic Hepatitis B
(Turk J Gastroenterol 2016; 27: 210-215)
DOI: 10.5152/tjg.2016.15521
New modalities in the treatment of HCV in pre and post - transplantation setting
(Turk J Gastroenterol 2015; 26: 204-213)
DOI: 10.5152/tjg.2015.0204
Non-invasive diagnosis of esophageal varices after Baveno VI
(Turk J Gastroenterol 2017; 28: 159-165)
DOI: 10.5152/tjg.2017.16744
Case Report
A case of gynecomastia due to entecavir
(Turk J Gastroenterol 2010; 21: 313-316)
DOI: 10.4318/tjg.2010.0108
Alström syndrome with liver cirrhosis: First case from Turkey
(Turk J Gastroenterol 2013; 24: 546-548)
DOI: 10.4318/tjg.2013.0587
A case of entecavir resistance which is developed after complete viral suppression during entecavir treatment for nucleoside-naive chronic hepatitis B
(Turk J Gastroenterol 2014; 25: 206-209)
DOI: 10.5152/tjg.2014.3605
Spontaneous splenic infarction in an elderly cirrhotic patient with multiple comorbidities
(Turk J Gastroenterol 2012; 23: 596-598)
DOI: 10.4318/tjg.2012.0429
Cyclosporine rescue therapy in autoimmune liver cirrhosis: A case report
(Turk J Gastroenterol 2012; 23: 599-603)
DOI: 10.4318/tjg.2012.0438
Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver
(Turk J Gastroenterol 2014; 25: 209-211)
DOI: 10.5152/tjg.2014.6188
Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension
(Turk J Gastroenterol 2014; 25: 429-432)
DOI: 10.5152/tjg.2014.7688
Hepatocellular carcinoma presenting as a huge intra-abdominal mass: A case report
(Turk J Gastroenterol 2014; 25: 330-332)
DOI: 10.5152/tjg.2014.3255
Original Article
The long-term mortality of spontaneous bacterial peritonitis in cirrhotic patients: A 3-year nationwide cohort study
(Turk J Gastroenterol 2015; 26: 159-162)
DOI: 10.5152/tjg.2015.4829
Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis
(Turk J Gastroenterol 2014; 25: 147-152)
DOI: 10.5152/tjg.2014.4888
Serum iron parameters in cirrhosis and chronic hepatitis: Detailed description
(Turk J Gastroenterol 2011; 22: 606-611)
DOI: 10.4318/tjg.2011.0323
Additional BCAA-enriched nutrient mixture improves the nutritional condition in cirrhotic patients with hypoalbuminemia despite treatment with regular BCAA granules: A pilot study
(Turk J Gastroenterol 2015; 26: 328-335)
DOI: 10.5152/tjg.2015.0202
18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma
(Turk J Gastroenterol 2015; 26: 344-350)
DOI: 10.5152/tjg.2015.0152
The incidence and risk factors of portal vein system thrombosis after splenectomy and pericardial devascularization
(Turk J Gastroenterol 2015; 26: 423-428)
DOI: 10.5152/tjg.2015.0063
Gallstones in liver transplant recipients: A single-center study in China
(Turk J Gastroenterol 2015; 26: 429-434)
DOI: 10.5152/tjg.2014.6344
AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C
(Turk J Gastroenterol 2011; 22: 279-285)
DOI: 10.4318/tjg.2011.0213
AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 353-358)
DOI: 10.4318/tjg.2012.0348
Noninvasive assessment of portal hypertension in patients with alcoholic cirrhosis
(Turk J Gastroenterol 2012; 23: 239-246)
DOI: 10.4318/tjg.2012.0463
Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 247-252)
DOI: 10.4318/tjg.2012.0380
Investigation into bacteremia and spontaneous bacterial peritonitis in patients with liver cirrhosis in Japan
(Turk J Gastroenterol 2012; 23: 122-126)
DOI: 10.4318/tjg.2012.0321
Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients
(Turk J Gastroenterol 2012; 23: 538-545)
DOI: 10.4318/tjg.2012.0358
Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis
(Turk J Gastroenterol 2012; 23: 560-568)
DOI: 10.4318/tjg.2012.0538
Alpha-1 antitrypsin deficiency in patients with chronic hepatitis
(Turk J Gastroenterol 2012; 23: 569-573)
DOI: 10.4318/tjg.2012.0379
Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience
(Turk J Gastroenterol 2013; 24: 141-147)
DOI: 10.4318/tjg.2013.0709
Clinical features of elderly Chinese patients with autoimmune hepatitis
(Turk J Gastroenterol 2013; 24: 489-494)
DOI: 10.4318/tjg.2013.0592
MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi
(Turk J Gastroenterol 2011; 22: 158-164)
DOI: 10.4318/tjg.2011.0185
Mean arterial pressure drop is an independent risk factor of death in patients with HBV-related cirrhosis ascites
(Turk J Gastroenterol 2017; 28: 26-30)
DOI: 10.5152/tjg.2016.0412
Glutathione and glutathione S-transferase levels in patients with liver metastases of colorectal cancer and other hepatic disorders
(Turk J Gastroenterol 2016; 27: 336-341)
DOI: 10.5152/tjg.2016.15457
Insight into the natural history of primary biliary cirrhosis: A systemic review of data from placebo-controlled clinical trials
(Turk J Gastroenterol 2016; 27: 342-348)
DOI: 10.5152/tjg.2016.15535
Hepatic granulomas in Turkey: A 6-year clinicopathological study of 35 cases
(Turk J Gastroenterol 2014; 25: 524-528)
DOI: 10.5152/tjg.2014.5417
Cirrhosis with ascites: Is the presence of hemorrhagic ascites an indicator of poor prognosis?
(Turk J Gastroenterol 2016; 27: 349-353)
DOI: 10.5152/tjg.2016.160042
Cirrhotic Ascites management via procalcitonin level and a new approach B-mode gray-scale histogram
(Turk J Gastroenterol 2016; 27: 47-54)
DOI: 10.5152/tjg.2015.150345
Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?
(Turk J Gastroenterol 2016; 27: 55-61)
DOI: 10.5152/tjg.2015.150280
Evaluation of local tumor residue after percutaneous radiofrequency ablation therapy for hepatocellular carcinoma
(Turk J Gastroenterol 2017; 28: 197-201)
DOI: 10.5152/tjg.2017.16641
Effect of coronary-caval shunt combined with partial pericardial devascularisation on oesophageal and gastric variceal bleeding caused by portal hypertension
(Turk J Gastroenterol 2016; 27: 354-360)
DOI: 10.5152/tjg.2016.16086
The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C
(Turk J Gastroenterol 2016; 27: 156-164)
DOI: 10.5152/tjg.2015.150449
Routinely evaluated clinical assays and laboratory tests [real test] and fibrosis stages of chronic hepatitis B and C
(Turk J Gastroenterol 2014; 25: 539-545)
DOI: 10.5152/tjg.2014.6170
Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis
(Turk J Gastroenterol 2015; 26: 244-250)
DOI: 10.5152/tjg.2015.0074
The relation between liver histopathology and GGT levels in viral hepatitis: More important in hepatitis B
(Turk J Gastroenterol 2014; 25: 411-415)
DOI: 10.5152/tjg.2014.3693
The association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C: An observational, multicenter study in Turkey
(Turk J Gastroenterol 2014; 25: 546-552)
DOI: 10.5152/tjg.2014.7829
The importance of salivary cortisol in the diagnosis of adrenal insufficiency in cirrhosis
(Turk J Gastroenterol 2016; 27: 268-272)
DOI: 10.5152/tjg.2016.15544
Variceal bleeding in cirrhotic patients: What is the best prognostic score?
(Turk J Gastroenterol 2016; 27: 464-469)
DOI: 10.5152/tjg.2016.16250
Galactin-3 and brain natriuretic peptide versus conventional echocardiography in the early detection of cirrhotic cardiomyopathy
(Turk J Gastroenterol 2016; 27: 367-374)
DOI: 10.5152/tjg.2016.16100
Is there any potential or additive effect of anemia on hepatorenal syndrome?
(Turk J Gastroenterol 2016; 27: 273-278)
DOI: 10.5152/tjg.2016.16029
Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone
(Turk J Gastroenterol 2016; 27: 375-381)
DOI: 10.5152/tjg.2016.15523
KDIGO (Kidney Disease: Improving Global Outcomes) criteria as a predictor of hospital mortality in cirrhotic patients
(Turk J Gastroenterol 2016; 27: 173-179)
DOI: 10.5152/tjg.2016.15467
Autonomic neuropathy and gallbladder motility in patients with liver cirrhosis
(Turk J Gastroenterol 2015; 26: 254-258)
DOI: 10.5152/tjg.2015.4469
Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study
(Turk J Gastroenterol 2016; 27: 180-186)
DOI: 10.5152/tjg.2016.15502
Incidence, causes, and outcomes of renal failure among cirrhotic patients
(Turk J Gastroenterol 2015; 26: 517-521)
DOI: 10.5152/tjg.2015.15169
Clinical features in liver cirrhosis patients who have experienced ischemic stroke
(Turk J Gastroenterol 2014; 25: 696-701)
DOI: 10.5152/tjg.2014.5959
Outcomes and predictors of in-hospital mortality among cirrhotic patients with non-variceal upper gastrointestinal bleeding in upper Egypt
(Turk J Gastroenterol 2014; 25: 707-713)
DOI: 10.5152/tjg.2014.6710
Liver - Original Article
Adverse factors responsible for below-normal platelet count after laparoscopic splenectomy and azygoportal disconnection
(Turk J Gastroenterol 2019; 30: 254-259)
DOI: 10.5152/tjg.2018.18207
Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey
(Turk J Gastroenterol 2019; 30: 331-335)
DOI: 10.5152/tjg.2018.18269
Percutaneous microwave ablation for HCV-related hepatocellular carcinoma: Efficacy, safety, and survival
(Turk J Gastroenterol 2019; 30: 445-453)
DOI: 10.5152/tjg.2019.17191
Increased occurrence of brain abscesses in cirrhotic patients: A population-based 3-year follow-up study
(Turk J Gastroenterol 2017; 28: 342-346)
DOI: 10.5152/tjg.2017.6374
Bacteremia in cirrhotic patients with upper gastrointestinal bleeding
(Turk J Gastroenterol 2018; 29: 164-169)
DOI: 10.5152/tjg.2018.17309
Platelet count to splenic diameter ratio and other noninvasive markers as predictors of esophageal varices in patients with liver cirrhosis
(Turk J Gastroenterol 2017; 28: 347-352)
DOI: 10.5152/tjg.2017.17090
Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound
(Turk J Gastroenterol 2017; 28: 446-452)
DOI: 10.5152/tjg.2017.17104
Regular hospital visits improve the prognosis of hepatocellular carcinoma after initial diagnosis: A single regional community hospital study
(Turk J Gastroenterol 2017; 28: 353-360)
DOI: 10.5152/tjg.2017.17163
The relationship between fibrosis and nodule structure and esophageal varices
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2019.18665
Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels
(Turk J Gastroenterol 2018; 29: 299-307)
DOI: 10.5152/tjg.2018.17570
Assessing the outcome of patients with liver cirrhosis during hospital stay: A comparison of lymphocyte/monocyte ratio with MELD and Child-Pugh scores
(Turk J Gastroenterol 2018; 29: 308-315)
DOI: 10.5152/tjg.2018.17631
Laparoscopic splenectomy and azygoportal disconnection combining with pre- and postoperative endoscopic intervention - A sandwich-style sequential therapy for portal hypertensive bleeding: A retrospective cohort study
(Turk J Gastroenterol 2018; 29: 669-675)
DOI: 10.5152/tjg.2018.18106
Does steatosis affect the performance of diffusion-weighted MRI values for fibrosis evaluation in patients with chronic hepatitis C genotype 4?
(Turk J Gastroenterol 2017; 28: 283-288)
DOI: 10.5152/tjg.2017.16640
Prospective randomized single-blind study of post-operative bleeding after minor oral surgery in patients with cirrhosis
(Turk J Gastroenterol 2019; 30: 171-176)
DOI: 10.5152/tjg.2018.18078
Safety and effectiveness of midazolam for cirrhotic patients undergoing endoscopic variceal ligation
(Turk J Gastroenterol 2018; 29: 448-455)
DOI: 10.5152/tjg.2018.17589
Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study
(Turk J Gastroenterol 2018; 29: 464-472)
DOI: 10.5152/tjg.2018.16597
Percutaneous microwave ablation for HCV-related hepatocellular carcinoma: Efficacy, safety, and survival
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2019.17191
Laparoscopic splenectomy and azygoportal disconnection combining with pre- and postoperative endoscopic intervention - A sandwich-style sequential therapy for portal hypertensive bleeding: A retrospective cohort study
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.18106
Safety and effectiveness of midazolam for cirrhotic patients undergoing endoscopic variceal ligation
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17589
Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.16597
Basic & Translational - Original Article
Claudin-9 enhances the metastatic potential of hepatocytes via Tyk2/Stat3 signaling
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2019.18513
Treatment with milk thistle extract (Silybum marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: Role of the hepatic stem cells
(Turk J Gastroenterol 2017; 28: 476-484)
DOI: 10.5152/tjg.2017.16742
An in vivo RNAi mini-screen in Drosophila cancer models reveals novel potential Wnt targets in liver cancer
(Turk J Gastroenterol 2019; 30: 198-207)
DOI: 10.5152/tjg.2018.18241
Pancreatobiliary - Original Article
Relationship between the neutrophil-to-lymphocyte ratio in acute pancreatitis and the severity and systemic complications of the disease
(Turk J Gastroenterol 2018; 29: 684-691)
DOI: 10.5152/tjg.2018.17563
Oral Presentation
Effects of small molecule inhibitors on liver cancer stem cells in comparison with Sorafenib
(Turk J Gastroenterol 2019; 30: 7-7)
DOI: 10.5152/tjg.2019.05
Assessment of sleep pattern and quality before and after liver transplantation using different methods
(Turk J Gastroenterol 2019; 30: 8-8)
DOI: 10.5152/tjg.2019.06
Poster
Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience
(Turk J Gastroenterol 2019; 30: 10-15)
DOI: 10.5152/tjg.2019.07
Nonsirotic chronic hepatitis B presenting with hepatocellular carcinoma: a case report
(Turk J Gastroenterol 2019; 30: 16-17)
DOI: 10.5152/tjg.2019.08
From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis
(Turk J Gastroenterol 2019; 30: 26-28)
DOI: 10.5152/tjg.2019.15
Unusal case of imunlogical liver dissease coexisting with chronic calculous cholecystitis and anatomical variation of billiary duct
(Turk J Gastroenterol 2019; 30: 33-33)
DOI: 10.5152/tjg.2019.19
Successfully treatment of chronic hepatitis C with direct-acting antiviral agents: a single center experience
(Turk J Gastroenterol 2019; 30: 34-34)
DOI: 10.5152/tjg.2019.20
Diastolic dysfunction in patients with cirrhosis and the relationship between the clinical and laboratory findings and diastolic dysfunction
(Turk J Gastroenterol 2019; 30: 35-35)
DOI: 10.5152/tjg.2019.21
Efficacy of entecavir treatment for up to 5 years in patients with HBV-related compensated cirrhosis in Turkey; real life data
(Turk J Gastroenterol 2019; 30: 36-36)
DOI: 10.5152/tjg.2019.22
A real-life evaluation of the effect of direct-acting antivirals in hemodialysis patients with chronic hepatitis C
(Turk J Gastroenterol 2019; 30: 39-40)
DOI: 10.5152/tjg.2019.25
Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medication with patients with chronic hepatitis C virus infection
(Turk J Gastroenterol 2019; 30: 43-45)
DOI: 10.5152/tjg.2019.28
Evaluation of 24-year followig results of patients with inactive hepatitis B
(Turk J Gastroenterol 2019; 30: 55-55)
DOI: 10.5152/tjg.2019.35
Diagnostic value of computerized tomography ın differential diagnosis of liver nodules
(Turk J Gastroenterol 2019; 30: 64-64)
DOI: 10.5152/tjg.2019.41
Clinical characteristics of hepatocellular carcinoma: Results from central Anatolian region of Turkey
(Turk J Gastroenterol 2019; 30: 65-65)
DOI: 10.5152/tjg.2019.42
Etiology of cirrhosis changing trends over the years: A single-center turkish experience
(Turk J Gastroenterol 2019; 30: 66-66)
DOI: 10.5152/tjg.2019.43
Liver biopsy may not be the optimal option for assessing treatment efficacy in chronic hepatitis delta (CHD) infection
(Turk J Gastroenterol 2019; 30: 67-67)
DOI: 10.5152/tjg.2019.44
Serum prolidase could be a marker for fibrosis/cirrhosis?
(Turk J Gastroenterol 2019; 30: 68-68)
DOI: 10.5152/tjg.2019.45
A case with chronic HBV infection who was non-responder to nucleos(t)ide analogues was treated with Pegylated interferon
(Turk J Gastroenterol 2019; 30: 70-72)
DOI: 10.5152/tjg.2019.47
Clinical and laboratory features of children with chronic hepatitis B infection: A single center results
(Turk J Gastroenterol 2019; 30: 74-74)
DOI: 10.5152/tjg.2019.49
Acute liver ınjury in a patient with secondary syphilis and acute viral hepatitis B coinfection
(Turk J Gastroenterol 2019; 30: 75-75)
DOI: 10.5152/tjg.2019.50
Clinical outcomes after cessation of potent antiviral treatment in chronic hepatitis B patients
(Turk J Gastroenterol 2019; 30: 81-82)
DOI: 10.5152/tjg.2019.54
Awareness of hepatitis C
(Turk J Gastroenterol 2019; 30: 85-85)
DOI: 10.5152/tjg.2019.56
Diagnosis ways of chronic HBV cases
(Turk J Gastroenterol 2019; 30: 86-86)
DOI: 10.5152/tjg.2019.57
Poster Presentation
Psychometric test compliance of patients with cirrhosis in the diagnosis of minimal hepatic encephalopathy
(Turk J Gastroenterol 2019; 30: 95-96)
DOI: 10.5152/tjg.2019.63
The evaluation of liver biopsy specimens of chronic hepatitis B patients using early tissue markers for Hepatocellular Carcinoma: Before and after the development of Hepatocellular Carcinoma
(Turk J Gastroenterol 2019; 30: 102-102)
DOI: 10.5152/tjg.2019.67
Changing in the etiologies and the presentation charactheristics in hepatocellular carcinoma. A single center experience in western Turkey
(Turk J Gastroenterol 2019; 30: 103-105)
DOI: 10.5152/tjg.2019.68
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2019 Turkish Society of Gastroenterology | Latest Update: 09.05.2019